MD-PhD, ACS - Atherosclerosis & Ischemic Syndromes Standard PhD Candidate, ACS - Atherosclerosis & Ischemic Syndromes MD-PhD, ANS - Cellular & Molecular Mechanisms Standard PhD Candidate, ANS - Cellular & Molecular Mechanisms MD-PhD, ANS - Systems & Network Neuroscience Standard PhD Candidate, ANS - Systems & Network Neuroscience Standard PhD Candidate, APH - Methodology MD-PhD, APH - Methodology Affiliatie UvA Standard PhD Candidate, Doctoral School Ophthalmology

Specialization

Ophthalmology, vascular retinal disorders

Focus of research

As a PhD candidate i am participating in the BRVO and BRDME studies: two randomized, controlled, double masked, clinical trials. Both studies compare the effectiveness and costs of bevacizumab to ranibizumab in patients with retinal veins occlusions and diabetic macular edema respectively. It is hypothisized that bevacizumab is non-inferior to ranibizumab regarding effectiveness in both studies.

Besides the clinical outcomes, we will analyse blood plasma from included patients to look for potential biomarkers. We will evaluate the diagnostic value of individual or combinations of selected candidate biomarkers of diabetic retinopathy. Finding reliable biomarkers for diabetic retinopathy would facilitate early diagnoses and therefore early treatment.